-
Swedish Orphan Biovitrum AB is an
international biopharmaceutical company dedicated to
treatments in the
areas of haematology,
immunology and specialty...
-
interleukin 1
receptor antagonist protein. It is
marketed by
Swedish Orphan Biovitrum.
Anakinra is
administered by
subcutaneous injection. It is used as a second...
-
remnant of the Stockholm-based part of
Pharmacia was
partly spun off to
Biovitrum in 2001,
which sold off its
plasma products division to
Octapharma in...
- deficiency. The
applicant for this
medicinal product is
Swedish Orphan Biovitrum.
Altuvoct was
approved for
medical use in the
European Union in June 2024...
-
Palifermin (trade name Kepivance,
marketed by
Biovitrum) is a
truncated human recombinant keratinocyte growth factor (KGF)
produced in
Escherichia coli...
-
Orphan Biovitrum, in
December 2008)
Kineret (anakinra) for
rheumatoid arthritis,
exclusively licensed to Biovitrium, now
Swedish Orphan Biovitrum, in December...
-
Swedish Orphan International,
which was
later acquired by
Swedish Orphan Biovitrum (Sobi).[citation needed] "Health
Canada New Drug Authorizations: 2016...
- )
Sunovion (formerly Sepracor) (1984– )
Sutro (2003– )
Swedish Orphan Biovitrum (2001– )
Synthon (1991– )
Taisho (1912– )
Takeda (1781– ) Taro (1950–...
- It was
developed by
Amgen and sold to Biovitrium, now
Swedish Orphan Biovitrum, in December, 2008. It is a 166
amino acid
protein produced by E. coli...
- hemoglobinuria. The
applicant for this
medicinal product is
Swedish Orphan Biovitrum AB (publ).
Pegcetacoplan was
approved for the
treatment of paroxysmal...
